Research Articles (Biotechnology)

Permanent URI for this collection

https://hdl.handle.net/10566/16116

Browse

Browsing by Author "Sibuyi, Nicole Remaliah Samantha"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Heterocyclic (pyrazine)carboxamide Ru(II) complexes: structural, experimental and theoretical studies of interactions with biomolecules and cytotoxicity†
    (Royal Society of Chemistry, 2024) Tsaulwayo, Nokwanda; Sibuyi, Nicole Remaliah Samantha; Meyer, Mervin
    Treatments of N-(1H-benzo[d]imidazol-2-yl)pyrazine-2-carboxamide (HL1) and N-(benzo[d]thiazol-2-yl)pyrazine-2-carboxamide carboxamide ligands (HL2) with [Ru(p-cymene)Cl2]2 and [Ru(PPh3)3Cl2] precursors afforded the respective Ru(ii) complexes [Ru(L1)(p-cymene)Cl] (Ru1), [Ru(L2)(p-cymene)Cl] (Ru2), [Ru(L1)(PPh3)2Cl] (Ru3), and [Ru(L2)(PPh3)2Cl] (Ru4). These complexes were characterized by NMR, FT-IR spectroscopies, mass spectrometry, elemental analyses, and crystal X-ray crystallography for Ru2. The molecular structure of complex Ru2 contains one mono-anionic bidentate bound ligand and display pseudo-octahedral piano stool geometry around the Ru(ii) atom. The interactions with calf thymus DNA (CT-DNA) and bovine serum albumin (BSA) were investigated by spectroscopic techniques. The experimental binding studies suggest that complexes Ru1-Ru4 interact with DNA, primarily through minor groove binding, as supported by molecular docking results. Additionally, these complexes exhibit strong quenching of the fluorescence of tryptophan residues in BSA, displaying static quenching. The in vitro cytotoxicity studies of compounds Ru1-Ru4 were assessed in cancer cell lines (A549, PC-3, HT-29, Caco-2, and HeLa), as well as a non-cancer line (KMST-6). Compounds Ru1 and Ru2 exhibited superior cytotoxicity compared to Ru3 and Ru4.
  • Thumbnail Image
    Item
    Phytonanotherapeutic applications of plant extract-synthesized silver nanoparticles in wound healing—a prospective overview
    (Springer, 2024) Oselusi, Samson Olaitan; Sibuyi, Nicole Remaliah Samantha; Madiehe, Abram Madimabe
    Chronic wounds continue to pose severe threats to public health and the global economy. This is because the healing process is hindered by several factors, such as bacterial infections, comorbid conditions, age, and lifestyle. Medical wound therapy is currently based on long-term antibiotic use, and its activity has been limited by various factors, including treatment efficacy, toxicity, and increased risk of opportunistic infections. The advent of novel techniques such as nanotechnology can provide sustainable platforms for developing reliable, cost-effective, and innovative wound healing interventions. In this context, plant extract-synthesized silver nanoparticles (AgNPs) have become attractive to the clinical community because of their wide range of biological properties, such as antibacterial, anti-inflammatory, and wound healing effects. These AgNPs could be used in the development of better dressings for wounds.